{"id":386567,"date":"2020-11-23T07:33:28","date_gmt":"2020-11-23T12:33:28","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=386567"},"modified":"2020-11-23T07:33:28","modified_gmt":"2020-11-23T12:33:28","slug":"crinetics-pharmaceuticals-to-participate-in-december-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/","title":{"rendered":"Crinetics Pharmaceuticals to Participate in December Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, Nov.  23, 2020  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=inylrPygsinzOEs1itF-_47-yLVj0Evsmok7PC9L0XwZBW-1vfHvQf22B-ipDd4Zbiv0seh_26_hqmaEtlJ33BSU-INXX-kp5nDEIx2HTjH68yPuFMy2nOp5QhYosC5YQ1aks077AaMJMAPw-Uo83lSvC3GOnjateT5iciiniIrB82eAmZdFTVkxI4qQh7E-\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Crinetics Pharmaceuticals\u00a0<\/a>(Nasdaq:\u00a0CRNX), today announced that company management will participate in the following conferences in the month of December. Please see additional details below:\u00a0\u00a0<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"3\">\n            <em><br \/>\n              <u>Evercore ISI 3<sup>rd<\/sup> Annual HealthCONx Conference<\/u><br \/>\n            <\/em>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:6%;width:6%;min-width:6%\"> Date: <\/td>\n<td style=\"max-width:1%;width:1%;min-width:1%\">\u00a0<\/td>\n<td style=\"max-width:93%;width:93%;min-width:93%\"> Thursday, December 3<sup>rd<\/sup>, 2020 <\/td>\n<\/tr>\n<tr>\n<td> Time: <\/td>\n<td>\u00a0<\/td>\n<td> 1:00 &#8211; 1:45 pm ET in Track 1 <\/td>\n<\/tr>\n<tr>\n<td> Panel: <\/td>\n<td>\u00a0<\/td>\n<td>\n            <em>Easy Pills to Swallow: Oral Drugs for Large Endo Markets<\/em>\n          <\/td>\n<\/tr>\n<tr>\n<td> Presenter: <\/td>\n<td>\u00a0<\/td>\n<td> Dr. Scott Struthers,\u00a0Founder\u00a0&amp; CEO <\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<tr>\n<td colspan=\"3\">\n            <em><br \/>\n              <u>Piper Sandler&#8217;s 32<sup>nd<\/sup> Annual Healthcare Conference<\/u><br \/>\n            <\/em>\n          <\/td>\n<\/tr>\n<tr>\n<td> Date: <\/td>\n<td>\u00a0<\/td>\n<td> Tuesday &#8211; Thursday, December 1<sup>st<\/sup> &#8211; 3<sup>rd<\/sup>,\u00a02020 <\/td>\n<\/tr>\n<tr>\n<td> Time: <\/td>\n<td>\u00a0<\/td>\n<td> On demand <\/td>\n<\/tr>\n<tr>\n<td> Presenter: <\/td>\n<td>\u00a0<\/td>\n<td>\n            <a href=\"https:\/\/crinetics.com\/r-scott-struthers-ph-d-founder-chief-executive-officer\/?utm_source=globenewswire&amp;utm_medium=backlink&amp;utm_campaign=press-release\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n              <u>Dr. Scott Struthers<\/u><br \/>\n            <\/a>,\u00a0Founder\u00a0&amp; CEO, and <a href=\"https:\/\/crinetics.com\/alan-s-krasner-m-d-chief-medical-officer\/?utm_source=globenewswire&amp;utm_medium=backlink&amp;utm_campaign=press-release\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Dr. Alan Krasner<\/u><\/a>, Chief Medical Officer <\/td>\n<\/tr>\n<tr>\n<td> Webcast: <\/td>\n<td>\u00a0<\/td>\n<td> Pre-recorded fireside chats are available for the annual <a href=\"https:\/\/crinetics.com\/32nd-annual-piper-sandler-healthcare-conference\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Piper Sandler Healthcare Conference<\/u><\/a> on the Events section on the Company\u2019s website as well as on the Piper Sandler conference website. <\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong>About Crinetics Pharmaceuticals\u00a0<br \/><\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=inylrPygsinzOEs1itF-_47-yLVj0Evsmok7PC9L0Xw9agkUAndWpDsI0Zxw43i36hIPNRtuJ5xS4FfRMrYO2bkWeiHvO55Ux61r-nPIqFJ6BJx-3L_FwEL05YBhNMvvaq2QGwNoJaoRWI0bUr3YJcmHJVSKXnyv30--bYXaKXUwuMR2h8l77Y-aL4MSjl-SEbglmHRnuCmhDiNc5q5reg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Crinetics Pharmaceuticals<\/a> is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company\u2019s lead product candidate, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jRo3onJA_fimIi9htXDLBmGw4KoBSecU_LEwciKF2_pKxm_ngzofluV0IeZ-Lz2SOHySfvXWZubgAIw5RCklBeeoPzsE0ikn-9nEHXp2zl5-FEBSIfuBEHOEebmQsJ7GyrsLLQqwRWctETzoFpfz8-XBjXqMheiEtgkyoO9ejo-C7eDpBboOe9wCfskqJdWBGIAKs14B0RFkX91HdjPLW0YPNgqpJzQ5vBgRnCrscrAtSjlTccybX8pmrq0znXgHJGCPv9HGhgvrYLkTkktIM1vCC-Am4zGEDfuDgXpiYsQDa928SbMWRz4Daogvxepr\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">paltusotine (formerly CRN00808)<\/a>, is an oral selective nonpeptide somatostatin receptor type 2 biased agonist for the treatment of acromegaly, an orphan disease affecting more than 25,000 people in the United States. Crinetics plans to advance paltusotine into a Phase 3 program in acromegaly and a Phase 2 trial for the treatment of carcinoid syndrome associated with NETs in 2021. The company is also developing <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zti7nzQcQ-qBHDZEuwXsN6Ie1FhPKdushatjFk8e2HMVZPKXY_SS4PPw5_AqB5YhL9uoRDlFFov7ICnT_utlIRTT0xlBgJfpszs7MhZMIXwrKLtnLsvoY1NpA-_SwI2rYBBBPzWkwtTTN8MMmMTihIiOWpJTVf8gcRq-WvFtVnbzjtI_rUQM6P-hm48TswiMR61uMFqgWXPzRXOvmowBpu6hTdCQxYQZrtG0-GjKdYBrtXAu4xwJy0sVq1y8Uzow\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">CRN04777<\/a>, an oral nonpeptide somatostatin receptor type 5 (SST5) agonist for congenital hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1sqHGT8XciIWitSQwKeVfHfjezyJGt7ptp9qgnvgKkaYr92OL-FG7gW8PPSoXEVUMV8yPrYzfbs_NavbXg28mHAyWQvVNDs2cBSifYRU8hCVzto9TQcoedRvQ3fQ29VX9HzwAE58WUEQuwh9jzZoHP_V3P568iTO0jdgBhhH4_jFMKX2QDCZ4du8nOWvfJgaNKisDtmPNTM9qEFJivlkuYleP2LdEA2vqqFhRMw7xpdo-tnQjU1RDpgqTSEGHVvbpmWZ1iOqzgRvbUPigWXB426fHz46KWnKms4pvZefCHQhA7HnDup827K1__VHDJ7XfKcuABC7oiomXtdeGAoAgg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Cushing\u2019s disease, congenital adrenal hyperplasia<\/a> and other diseases of excess ACTH. All of the company\u2019s drug candidates are new chemical entities resulting from in-house drug discovery efforts and are wholly owned by the company. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YUZrw6PUtqhsRVo-5T5Addc3ci0AuZvN5paYdNQJ8YU099cOlODgM0xBRrdUZwCcRi7vWmOok4ya-BF5ftS7Ij6-ohB2TsbeuBVL9uy4kujhb51QVoYyqX_DIc1H3S54UFzNeweLzNVla3FMdPolcB0OQS08Xc8Iw6DOGT7LWFRexE3-tyQi0qa5svvplI4Y\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/crinetics.com<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong><br \/>\n        <br \/>Marc Wilson<br \/>Chief Financial Officer<br \/>IR@crinetics.com <br \/>(858) 450-6464<\/p>\n<p>Investors \/ Media:<br \/>Corey Davis<br \/>LifeSci Advisors<br \/>cdavis@lifesciadvisors.com <br \/>(212) 915-2577<\/p>\n<p>Aline Sherwood<br \/>Scienta Communications<br \/>asherwood@scientapr.com<br \/>(312) 238-8957<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/4a865c90-852f-4665-9910-dcb73626f6b5\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals\u00a0(Nasdaq:\u00a0CRNX), today announced that company management will participate in the following conferences in the month of December. Please see additional details below:\u00a0\u00a0 Evercore ISI 3rd Annual HealthCONx Conference Date: \u00a0 Thursday, December 3rd, 2020 Time: \u00a0 1:00 &#8211; 1:45 pm ET in Track 1 Panel: \u00a0 Easy Pills to Swallow: Oral Drugs for Large Endo Markets Presenter: \u00a0 Dr. Scott Struthers,\u00a0Founder\u00a0&amp; CEO \u00a0 \u00a0 \u00a0 Piper Sandler&#8217;s 32nd Annual Healthcare Conference Date: \u00a0 Tuesday &#8211; Thursday, December 1st &#8211; 3rd,\u00a02020 Time: \u00a0 On demand Presenter: \u00a0 Dr. Scott Struthers ,\u00a0Founder\u00a0&amp; CEO, and Dr. Alan Krasner, Chief Medical Officer Webcast: \u00a0 Pre-recorded fireside chats are available for the annual Piper Sandler Healthcare &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Crinetics Pharmaceuticals to Participate in December Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-386567","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Crinetics Pharmaceuticals to Participate in December Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Crinetics Pharmaceuticals to Participate in December Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals\u00a0(Nasdaq:\u00a0CRNX), today announced that company management will participate in the following conferences in the month of December. Please see additional details below:\u00a0\u00a0 Evercore ISI 3rd Annual HealthCONx Conference Date: \u00a0 Thursday, December 3rd, 2020 Time: \u00a0 1:00 &#8211; 1:45 pm ET in Track 1 Panel: \u00a0 Easy Pills to Swallow: Oral Drugs for Large Endo Markets Presenter: \u00a0 Dr. Scott Struthers,\u00a0Founder\u00a0&amp; CEO \u00a0 \u00a0 \u00a0 Piper Sandler&#8217;s 32nd Annual Healthcare Conference Date: \u00a0 Tuesday &#8211; Thursday, December 1st &#8211; 3rd,\u00a02020 Time: \u00a0 On demand Presenter: \u00a0 Dr. Scott Struthers ,\u00a0Founder\u00a0&amp; CEO, and Dr. Alan Krasner, Chief Medical Officer Webcast: \u00a0 Pre-recorded fireside chats are available for the annual Piper Sandler Healthcare &hellip; Continue reading &quot;Crinetics Pharmaceuticals to Participate in December Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-23T12:33:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Crinetics Pharmaceuticals to Participate in December Investor Conferences\",\"datePublished\":\"2020-11-23T12:33:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/\"},\"wordCount\":318,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/\",\"name\":\"Crinetics Pharmaceuticals to Participate in December Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=\",\"datePublished\":\"2020-11-23T12:33:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Crinetics Pharmaceuticals to Participate in December Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Crinetics Pharmaceuticals to Participate in December Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Crinetics Pharmaceuticals to Participate in December Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Crinetics Pharmaceuticals\u00a0(Nasdaq:\u00a0CRNX), today announced that company management will participate in the following conferences in the month of December. Please see additional details below:\u00a0\u00a0 Evercore ISI 3rd Annual HealthCONx Conference Date: \u00a0 Thursday, December 3rd, 2020 Time: \u00a0 1:00 &#8211; 1:45 pm ET in Track 1 Panel: \u00a0 Easy Pills to Swallow: Oral Drugs for Large Endo Markets Presenter: \u00a0 Dr. Scott Struthers,\u00a0Founder\u00a0&amp; CEO \u00a0 \u00a0 \u00a0 Piper Sandler&#8217;s 32nd Annual Healthcare Conference Date: \u00a0 Tuesday &#8211; Thursday, December 1st &#8211; 3rd,\u00a02020 Time: \u00a0 On demand Presenter: \u00a0 Dr. Scott Struthers ,\u00a0Founder\u00a0&amp; CEO, and Dr. Alan Krasner, Chief Medical Officer Webcast: \u00a0 Pre-recorded fireside chats are available for the annual Piper Sandler Healthcare &hellip; Continue reading \"Crinetics Pharmaceuticals to Participate in December Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-23T12:33:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Crinetics Pharmaceuticals to Participate in December Investor Conferences","datePublished":"2020-11-23T12:33:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/"},"wordCount":318,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/","name":"Crinetics Pharmaceuticals to Participate in December Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=","datePublished":"2020-11-23T12:33:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDE5NSMzODM4NDU4IzIwODk4MTU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/crinetics-pharmaceuticals-to-participate-in-december-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Crinetics Pharmaceuticals to Participate in December Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=386567"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386567\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=386567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=386567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=386567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}